Datopotamab deruxtecan: Data from P1 TROPION-PanTumor01 trial (NCT03401385) for solid tumors in 2024 (AstraZeneca) - Apr 26, 2023 - Q1 2023 Results: Data from P3 TROPION-Breast01 trial (NCT05104866) for inoperable or metastatic HR+, HER2- breast cancer in H2 2023
P1 data • P3 data • Breast Cancer • HER2 Negative Breast Cancer • Oncology • Solid Tumor
|